29 results on '"C. Berkowski"'
Search Results
2. Multicenter Comparison Study of both Analytical and Clinical Performance across Four Roche Hepatitis C Virus RNA Assays Utilizing Different Platforms
3. RAVs Datenbank: Untersuchung der Häufigkeit und Charakteristika von RAVs bei therapienaiven und DAA-erfahrenen Patienten
4. Therapieauswahl von verschiedenen Kombinationen direkt antiviraler Agenzien anhand des Vorhandenseins von Resistenz-assoziierten Varianten zu baseline führt zu hohen Heilungsraten in Hepatitis C Genotyp 1 infizierten Patienten mit und ohne Leberzirrhose
5. Genotypen-spezifische Prävalenz und Bedeutung natürlich vorkommender Precore-, Basal Core Promotor- und preS-Mutationen in einer großen europäischen Studienkohorte bei chronisch mit dem Hepatitis B Virus infizierten Patienten
6. Assoziation zwischen IFN-L3(IL28B) und IFN-L4 Genotypen mit DAA-Resistenz-assoziierten HCV-Varianten in Genotyp 1 und 3 infizierten Patienten
7. Berücksichtigung viraler Resistenzen zur Optimierung der direkt antiviralen Therapie von Patienten mit chronischer Genotyp 1 Hepatitis C Virusinfektion
8. Untersuchung von Resistenzmutationen innerhalb der NS3 Protease zur Vorhersage des Therapieausgangs der HCV Triple-Therapie
9. Variations in serum sphingolipid levels associate with liver fibrosis progression and poor treatment outcome in hepatitis C virus but not hepatitis B virus infection
10. P0900 : Consideration of viral resistance for optimization of direct antiviral therapy of chronic hepatitis C
11. P0721 : Viral and host parameters in association with outcome of acute hepatitis C in HIV-coinfected patients
12. P0766 : Epidemiology of viral resistance in genotype 1 infected patients at approval of IFN-free DAA combination therapy of chronic hepatitis C in Germany
13. Investigation of NS3 Protease Resistance-Associated Variants and Phenotypes for the Prediction of Treatment Response to HCV Triple Therapy
14. European Ravs Database: Frequency and Characteristics of Ravs in Treatment-Naïve and DAA-Experienced Patients
15. Direct Antiviral Combination Treatment According to Presence of Baseline Ravs in NS3, NS5A and NS5B Leads to High SVR Rates in Non-Cirrhotic and Cirrhotic Genotype 1 Infected Patients
16. Consideration of Viral Resistance for Optimization of Direct Antiviral Therapy of Hepatitis C Virus Genotype 1-Infected Patients
17. P0895 : Comparison of three sequencing methods commonly used in hepatitis C virus resistance analysis: population-based vs. clonal vs. ultra deep sequencing
18. P0728 : Investigation of genetic recombination of hepatitis C virus in patients infected with genotypes 1, 2 and 4
19. P0818 : Analysis of NS3 protease resistance-associated variants and phenotypes for the prediction of treatment response to HCV triple therapy
20. P0877 : HCVRNA levels assessed at early stages of sofosbuvir/ribavirin dual therapy identify relapse patients
21. Evolution and function of the HCV NS3 protease in patients with acute hepatitis C and HIV coinfection
22. Elimination of hepatitis C virus has limited impact on the functional and mitochondrial impairment of HCV-specific CD8+ T cell responses.
23. Multicenter Comparison Study of both Analytical and Clinical Performance across Four Roche Hepatitis C Virus RNA Assays Utilizing Different Platforms.
24. Investigation of NS3 Protease Resistance-Associated Variants and Phenotypes for the Prediction of Treatment Response to HCV Triple Therapy.
25. Applicability of Hepatitis C Virus RNA Viral Load Thresholds for 8-Week Treatments in Patients With Chronic Hepatitis C Virus Genotype 1 Infection.
26. Interferon lambda 4 genotypes and resistance-associated variants in patients infected with hepatitis C virus genotypes 1 and 3.
27. Evolution and function of the HCV NS3 protease in patients with acute hepatitis C and HIV coinfection.
28. Consideration of Viral Resistance for Optimization of Direct Antiviral Therapy of Hepatitis C Virus Genotype 1-Infected Patients.
29. Variations in serum sphingolipid levels associate with liver fibrosis progression and poor treatment outcome in hepatitis C virus but not hepatitis B virus infection.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.